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Abstract
Hyperacute changes in cerebral blood flow during cerebral ischaemia and reperfusion are important determinants of
injury. Cerebral blood flow is regulated by neurovascular coupling, and disruption of neurovascular coupling contributes
to brain plasticity and repair problems. However, it is unknown how neurovascular coupling is affected hyperacutely
during cerebral ischaemia and reperfusion. We have developed a remote middle cerebral artery occlusion model in the
rat, which enables multi-modal assessment of neurovascular coupling immediately prior to, during and immediately
following reperfusion. Male Wistar rats were subjected to remote middle cerebral artery occlusion, where a long
filament was advanced intraluminally through a guide cannula in the common carotid artery. Transcallosal stimulation
evoked increases in blood flow, tissue oxygenation and neuronal activity, which were diminished by middle cerebral
artery occlusion and partially restored during reperfusion. These evoked responses were not affected by administration
of the thrombolytic alteplase at clinically used doses. Evoked cerebral blood flow responses were fully restored at 24 h
post–middle cerebral artery occlusion indicating that neurovascular dysfunction was not sustained. These data show for
the first time that the rat remote middle cerebral artery occlusion model coupled with transcallosal stimulation provides
a novel method for continuous assessment of hyperacute neurovascular coupling changes during ischaemia and reperfu-
sion, and offers unique insight into hyperacute ischaemic pathophysiology.
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Introduction
A wide variety of animal models have been used to
understand the pathophysiology of ischaemic stroke
as a means to identify biochemical events that can be
targeted to prevent neuronal cell death. As a result,
neuroprotective agents targeting the ischaemic cascade
have been trialled, but, as has been extensively
described, none of these have successfully translated
to the clinic for ischaemic stroke.1,2 This lack of eﬃcacy
could be accounted for by methodological diﬀerences
between the pre-clinical animal experiments and the
clinical trials.2 One critical diﬀerence is the time of
administration, with the hyperacute time points
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recognised as the critical periods for intervention to
restrict brain injury following stroke but patient recruit-
ment at this time can be limited. In addition, physio-
logical factors such as cerebral blood ﬂow (CBF) and
body temperature could account for the translational
failure of neuroprotective agents for stroke.3
Reduced CBF is an important mediator of cerebral
ischaemic injury. Animal models of both transient and
permanent middle cerebral artery occlusion (MCAO)
have demonstrated that the extent of CBF reduction
and restoration of CBF upon reperfusion is inversely
correlated with infarct volume, i.e. the greater the CBF,
the lesser the infarct.4,5 The regulation of CBF post-
ischaemia is therefore crucial for recovery, and under-
standing the pathological milieu associated with
changes in CBF immediately after the onset of ischae-
mia is critical in the development of adjunct therapies
for stroke.
The regulation of CBF is tightly controlled and
inﬂuenced by a number of mediators released from neu-
rons and astrocytes, which act directly or indirectly on
vascular smooth muscle cells and pericytes.6–8
Interestingly, a number of mediators that control
CBF also play an important role within the ischaemic
cascade, which leads to neuronal cell death, including
glutamate, intracellular Ca2þ increase, prostaglandin
formation and nitric oxide formation.1,7,8 This link
between the molecular determinants of ischaemic
stroke pathogenesis and CBF control can lead to neu-
rovascular deﬁcits,9 which may be associated with
impaired neuronal connectivity, plasticity and
repair.10–12 It is thought that neurovascular dysfunction
can persist for days and is dependent on the level of the
ischaemic insult.8 However, it is not known how neu-
rovascular coupling is aﬀected during ischaemia and
reperfusion in the hyperacute setting. Such knowledge
may shed light on new opportunities for pharmaco-
logical intervention to modulate hyperacute neurovas-
cular eﬀects.
Recombinant tissue plasminogen activator (rtPA;
administered as the formulation alteplase) is the only
approved thrombolytic treatment for ischaemic stroke,
but only a small proportion of patients receive bene-
ﬁt.13 It is usually administered as a 10% intravenous
bolus and the remaining 90% infused over 60min.
It has been shown that endogenous tPA plays a role
in neurovascular coupling through the nitric oxide
pathway.14 However, it is unknown how alteplase,
independent of its thrombolytic eﬀects, alters neurovas-
cular coupling during the ﬁrst hour of reperfusion fol-
lowing MCAO.
The aims of this study, therefore, were threefold.
First, to use a remote method for inducing MCAO
that enables continuous and uninterrupted (i.e. before,
during and after occlusion) assessment of neurovascular
function in vivo using a range of neurophysiological
and neuroimaging techniques. Second, to establish
how alteplase administration aﬀects neurovascular
function upon reperfusion following MCAO. Third,
to compare the results obtained under aim one with
those of a ‘conventional’ MCAO approach with meas-
urement of neurovascular function 24 h following tran-
sient occlusion–reperfusion. This approach will for the
ﬁrst time provide a novel method for continuous assess-
ment of hyperacute neurovascular coupling changes
during ischaemia and reperfusion, and will be a crucial
tool for investigating hyperacute pathophysiological
changes in the ischaemic brain.
Methods
Animals
All procedures conformed to the Animal (Scientiﬁc
Procedures) Act 1986 (UK) and the European
Council’s Convention for the Protection of Vertebrate
Animals Used for Experimental and Other Scientiﬁc
Purposes, and were approved by the University of
Oxford Animal Ethics Committee, the Home Oﬃce
(UK) and the Danish National Ethics Committee.
Experiments are reported in line with the ARRIVE
guidelines. Male Wistar rats (241–340 g, n¼ 26;
Harlan, UK or Charles River, Denmark) were used.
All animals were housed in a 12 h light/dark cycle and
had ad libitum access to food and water prior to
experiments.
Three cohorts of animals were used (see
Supplementary Figure 1 for ﬂow of rats through the
study). In the ﬁrst cohort (remote MCAO), the acute
eﬀects of occlusion–reperfusion on neurovascular
coupling were assessed under a single episode of non-
recovery general anaesthesia. The second cohort
(remote MCAOþ alteplase) was assessed for the neu-
rovascular eﬀects of occlusion–reperfusionþ alteplase
or vehicle(s) infusion, again under a single episode of
non-recovery general anaesthesia. The third cohort
(90min MCAO induced in the conventional
way5þ 22.5 h reperfusion) was used to determine the
eﬀects of transient MCAO upon neurovascular cou-
pling 22.5 h after occlusion–reperfusion.
Remote MCAO preparation
The remote MCAO model is a modiﬁcation of the con-
ventional intraluminal ﬁlament MCAO model previ-
ously described.5 This model allows the advancement
of the ﬁlament to occlude the MCA while the rat is
secured in a stereotaxic frame, and permits the assess-
ment of CBF and electrophysiological responses at very
acute time points following occlusion or ﬁlament
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retraction. Anaesthesia was induced with 4% isoﬂurane
and maintained with 1.5–2% isoﬂurane in 30–50%
oxygen and 70–50% nitrogen. Initially, the right fem-
oral artery was cannulated with polyethylene tubing
(ID 0.4mm, OD 0.8mm) for blood gas monitoring
and the right femoral vein was cannulated using the
same size tubing for administration of drugs or alpha-
chloralose anaesthesia as described below. After the
cannulations, the MCAO preparatory procedure
was carried out on the right side of the rat. A midline
incision was made in the neck, and the right external
carotid artery permanently ligated. The right common
carotid artery was permanently ligated and the internal
carotid and pterygopalatine arteries were isolated and
temporarily ligated. An arteriotomy was made in the
common carotid artery, and a guide cannula (poly-
ethylene tubing ID 0.4mm, OD 0.8mm, length
3–4 cm shorter than the length of the ﬁlament; Smiths
Medical (Ashford, UK)) was inserted into the common
carotid artery up to the beginning of the internal car-
otid artery. A custom-length 4-0 ﬁlament (10–15 cm,
Supplementary Fig 2A) with a silicon tip (0.37mm
diameter, 5–6mm in length; Doccol, Sharon, MA,
USA) was advanced through the guide cannula into
the internal carotid artery. The ﬁlament continued to
be advanced up the internal carotid artery past the
pterygopalatine branch until the silicon could no
longer be observed, at which point the ﬁlament was
secured (Supplementary Fig 2B). At this point, the ﬁla-
ment did not occlude the MCA, but a minor advance-
ment of the ﬁlament will be suﬃcient to produce an
occlusion. Following this, the rat was tracheotomised
and ventilated to enable breathing rate and tidal
volume to be altered to maintain blood gas values
within physiological ranges throughout the experiment
(pH 7.35–7.5, pCO2 30–45mmHg, pO2 90–150mmHg).
Core body temperature was maintained (37C)
throughout the procedure using a homeothermic heat-
ing pad attached to a rectal probe. Following prepara-
tory surgery for remote MCAO, animals were turned
over and placed into a stereotaxic frame, with the ﬁla-
ment and guide cannula remaining accessible. Each rat
then underwent preparation for assessment of neuro-
vascular coupling.
Neurovascular coupling assessment
After placement of the animal in a stereotaxic frame, a
midline incision of the scalp was made and the skin
retracted. Two equal 4mm 4 mm craniotomies with
a centre point at 3mm posterior and 4mm lateral to
bregma were drilled over the right (ipsilateral to ischae-
mia) and left (contralateral to ischaemia) somatosen-
sory cortex, which is a region that is supplied by the
MCA. In some cases, only small burr holes were drilled
on the skull over each hemisphere, rather than cranio-
tomies. Craniotomies were superfused with artiﬁcial
CSF (composition in mM): 120 NaCl, 2.8 KCl, 22
NaHCO3, 1.45 CaCl, 1.0 Na2HPO4 and 0.876 MgCl2,
pH 7.43, heated to 37C and bubbled with 5% CO2,
21% O2, 74% atmospheric air. MK-801 (1mM) was
applied topically to the contralateral craniotomy to
prevent seizure activity and spreading depression.15
Following completion of surgical procedures, anaesthe-
sia was switched to a-chloralose HBC complex in saline
initiated by i.v. bolus of 0.8 g/kg and maintained at
0.55 g/kg/h i.v. using an infusion pump. Either Laser
Speckle Contrast Imaging (LSCI) of both hemispheres
(Moor Instruments, Axminster, UK) or Laser Doppler
Flowmetry (LDF) of the ipsilateral (right) ischaemic
hemisphere only (Perimed, Ja¨rfa¨lla, Sweden) was used
to assess CBF on the surface of the brain, whilst a
modiﬁed Clark-type polarographic oxygen microelec-
trode (OX-10, Unisense) was used to monitor tpO2 at
approximate coordinates of 3mm posterior and 6mm
lateral to Bregma, at a depth of 300–600mm from the
ipsilateral cortical surface (see Fordsmann et al.16 for
further details). For some experiments, a glass micro-
electrode to record extracellular local ﬁeld potentials
was also placed in the ipsilateral cortex at a depth of
300–600mm to assess neuronal activity.16 Transcallosal
stimulation (10Hz, 0.2ms pulse width, 15–16 s dur-
ation, 2mA, 1 or 2min inter-stimulation interval
repeated for 3–10 trials) was initiated through a bipolar
stimulating electrode (Kopf Instruments, Tujunga, CA,
USA) placed in the left craniotomy/burr hole so its tip
was 300–600mm below the surface of the brain. This
stimulation evoked a response in CBF, tpO2 and neur-
onal activity in the right somatosensory cortex (ipsilat-
eral to MCAO, contralateral to stimulation), which was
recorded as described above (Supplementary Fig 2C).
The region of activation with transcallosal stimulation
as described above has previously been shown to evoke
responses in the somatosensory barrel cortex in a simi-
lar manner to infraorbital nerve stimulation, which
innervates the whisker pad.17
Cohort 1: Remote MCAO
After preparation for remote MCAO and neurovascular
coupling (see above), 11 rats had remote MCAO
induced by gently advancing the ﬁlament through the
guide cannula until a drop in CBF could be observed
using LSCI (Figure 1(a)) or LDF (Figure 1(b)). The ﬁla-
ment remained in place for a pre-determined period of
time and was retracted to produce reperfusion, as evi-
denced by a sharp increase in CBF (Figure 1(a) and (b)).
Transcallosal or whisker stimulation and evoked
response assessment as described above were carried
out prior to MCAO (but after common carotid artery
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Figure 1. Remote MCAO produces changes in resting CBF and tissue oxygenation. (a) Example Laser Speckle Contrast images of
the superficial cortex. Remote MCAO produces a significant drop in blood flow upon filament advancement over the ipsilateral
cortex. Filament retraction leads to a large increase in CBF throughout the ipsilateral cortex. Note that even pre-stroke, CBF is
reduced in the ipsilateral cortex compared with the contralateral cortex due to prior clamping of the CCA. (b) Remote MCAO:
example CBF trace of the induction of ischaemia with the remote MCAO model and restoration of CBF upon reperfusion. Note that
CCA was clamped prior to recording and so 100% CBF baseline is post-CCAO (approximately 65% of true baseline). Conventional
MCAO: example CBF trace of the induction of ischaemia with the conventional MCAO model and restoration of CBF upon
reperfusion while keeping the CCA ligated. (c) Resting CBF (averaged over each period; mean SD) revealing the effects of remote
MCAO and reperfusion on CBF after CCAO had already occurred. N¼ 6 per group. (d) Example trace of tpO2 following induction of
ischaemia with the remote MCAO model and restoration of tpO2 upon reperfusion. (e) Resting tpO2 (averaged over each period;
median range) revealing the effects of remote MCAO and reperfusion on tissue oxygenation. N¼ 3 per group.
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ligation, when CBF has partially been reduced), during
MCAO and during reperfusion. All remote MCAO
experiments (cohort 1þ cohort 2, n¼ 20) were con-
ducted under one non-recovery general anaesthesia
session.
Cohort 2: Remote MCAOþ alteplase
We used the remote MCAO model to assess whether
alteplase administration at the time of reperfusion
altered neurovascular coupling acutely. The remote
MCAO model and neurovascular coupling experiments
were carried out on the stereotaxic frame as described
above (n¼ 9). Remote MCAO duration was 90min,
which is a timepoint within the limits for alteplase treat-
ment and provides a moderate level of brain infarc-
tion.18 During remote MCAO, transcallosal
stimulations (10Hz, 0.2ms pulsewidth, 15 s duration,
3mA, 2min inter-stimulation interval repeated for at
least three trials) occurred at 1, 30, 60 and 80min
into MCAO. Reperfusion was produced through ﬁla-
ment retraction, and saline (n¼ 3), carrier (containing
31.5mg/kg L-arginine, 9mg/kg phosphoric acid and
0.1mg/kg polysorbate 80; n¼ 3) or alteplase (contain-
ing 0.9mg/kg r-tPA and the carrier (Boehringer
Ingelheim, Ingelheim, Germany); n¼ 3) was immedi-
ately administered with 10% of the dose as i.v. bolus
and 90% of the dose as an i.v. infusion lasting 1 h in
line with human stroke treatment. Animals were ran-
domly assigned to treatment group following conﬁrm-
ation of successful ischaemia and the researcher was
blind to the treatment group that was administered.
Transcallosal stimulations occurred at 3, 30 and
50min into the reperfusion period. CBF, tpO2 and
local ﬁeld potentials were monitored throughout the
reperfusion period. The timepoints for transcallosal
stimulation were chosen to obtain neurovascular assess-
ment as soon as possible after ischaemia and reperfu-
sion, while keeping evenly spaced (every 30min)
assessment throughout both periods. The last stimula-
tion occurred 10min before the end of each period due
to the duration of the stimulation protocol.
Cohort 3: Conventional MCAO with recovery
To determine whether any acute changes in neurovas-
cular coupling were sustained, six animals were ran-
domly assigned to undergo either 90min MCAO
using the conventional method or sham with a 22.5 h
recovery period, at which time neurovascular coupling
assessment was carried out. Conventional MCAO
was achieved through introduction of the ﬁlament
into the external carotid artery, which was advanced
to occlude the MCA for 90min as previously
described.5 Sham animals had the ﬁlament inserted
up to the pterygopalatine branch of the internal carotid
artery, but no further. The ﬁlament was retracted and
the common carotid artery ligation was removed for
reperfusion. LDF (Oxford Optronix, Oxford, UK)
was used to determine successful ischaemia and reper-
fusion.5,19 Each animal was then allowed to recover
from anaesthesia and placed in a recovery cage with
regular monitoring until neurovascular coupling assess-
ment. After 22.5 h of reperfusion, animals were assessed
for neurological deﬁcit using the modiﬁed Garcia neu-
roscore.5,20 Animals were then re-anaesthetised, tra-
cheotomised and ventilated, the femoral artery was
cannulated for blood gas monitoring (all blood gases
were within the limits described above) and the skull
over the ipsilateral somatosensory cortex (same
4mm 4mm area) thinned for LSCI. Animals under-
went neurovascular coupling assessment as described
above, with the following exceptions: stimulation
electrodes (Grass Technologies, Warwick, RI, USA)
were placed in the contralateral whisker pad of the
animal to evoke a response in the ipsilateral whisker
barrel cortex in the same region as transcallosal stimu-
lation; 1.25% isoﬂurane carried in 30% O2 and 70% N2
was used; no tpO2 measurements took place; whisker
pad was stimulated at either 3Hz or 10Hz, 0.3ms
pulsewidth, 16 s duration, 2mA, 1min inter-stimulation
interval repeated for 10 trials. Animals were then killed,
the brain dissected out, sliced into 2mm thick sec-
tions and stained for infarct location using 2,3,
5-triphenyltetrazolium chloride (TTC), as described
previously.5
Data analysis
LSCI CBF data were acquired using Moor FLPI soft-
ware (Moor Instruments), and exported to Matlab
(Mathworks, Natick, MA, USA) to determine changes
in both resting and evoked CBF over time. LDF CBF,
tPO2 data and local ﬁeld potential recordings were
obtained using Spike software (Cambridge Electrical
Design, Cambridge, UK) and analysed using Matlab.
Evoked responses were calculated as the amplitude of
the peak or the area under the curve of the entire
response. The cerebral metabolic rate for O2
(CMRO2) was calculated using the same method as
Fordsmann et al.16 All resting CBF, tpO2 and
CMRO2 data had a running average of 1min applied
before analysis of changes in response to remote
MCAO. All evoked CBF, tpO2 and CMRO2 data had
a running average of 1 s applied before analysis of
changes in response to transcallosal stimulation as
previously described.16 The running average analysis
method was used to smooth stochastic noise (see
Supplementary Fig 3). Data are presented as
mean standard deviation (SD) or median range
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and are annotated in the ﬁgure legends. Repeated
measures ANOVA followed by Tukey’s post-hoc test
was used to compare groups or Dunnet’s post-hoc test
when comparing to pre-MCAO group only. For correl-
ation analysis, a Pearson correlation coeﬃcient was
determined between two variables. p< 0.05 was
considered statistically signiﬁcant. All statistical tests
were two-sided and no further adjustment for multiple
comparison has been made for the overall number
of tests. Speciﬁc n numbers are stated for each experi-
ment in the results or ﬁgures. No power calculation
for sample size was used as a new model was being
developed and no estimate of eﬀect size could be
established.
Results
Cohort 1: Diminished evoked responses
after remote MCAO
Initially, we aimed to determine how the remote
MCAO model of stroke with the rat positioned on a
stereotaxic frame performed compared with the con-
ventional method of MCAO by studying a number of
diﬀerent parameters.5 Speciﬁcally, we assessed resting
CBF and tpO2 changes immediately following remote
MCAO and reperfusion. The LSCI and LDF data
showed that CBF was diminished upon advancement
of the ﬁlament to occlude the MCA (Suppl Movie 1),
and was restored by retracting the ﬁlament (Figure 1(a)
and (b), Suppl Movie 2). Quantiﬁcation of CBF
minima revealed that the remote MCAO model
reduced CBF in the superﬁcial cortex to
36.0% 14.4% (n¼ 6) of baseline (Tukey’s:
p¼ 0.0003; Supplementary Fig 4A). Average CBF
over the entire ischaemic period showed that remote
MCAO decreased CBF to 54.6% 12.6% (n¼ 6) of
baseline (Tukey’s: p¼ 0.0007; Figure 1(c)). Note that
CBF recording with the remote MCAO model could
only begin following common carotid artery occlusion
(CCAO) and ﬁlament placement (see methods, Figure
1(b)), and that CCAO CBF reduction using the con-
ventional MCAO method has previously been reported
by us to be 64.6% 11.9% (n¼ 44) of baseline.5
Therefore, transforming the CBF levels during remote
MCAO to include the extra drop by CCAO would
equate to a true relative minimum CBF of
23.2% 9.3% and average CBF of 35.3% 8.1%.
Retraction of the ﬁlament increased maximum CBF
to 210% 91% (Tukey’s: p¼ 0.0135, n¼ 6;
Supplementary Fig 4A) and average CBF to
156% 54% (Tukey’s: p¼ 0.0121, n¼ 6; Figure 1(c))
of post-CCAO baseline showing that the acute hyper-
emia upon reperfusion occurs in a similar manner
as with conventional MCAO. In addition to CBF,
the remote MCAO model also produced a decrease in
tpO2 upon MCAO (median 69% (range 51–97%) of
baseline throughout MCAO period, only n¼ 3 due to
technical problems with electrode) that was maintained
throughout the duration of ischaemia, and could be
restored upon reperfusion (Figure 1(d) and (e),
Supplementary Fig 4B).
Even though MK-801 was applied topically to the
contralateral cortex to prevent spreading depolariza-
tion due to electrical stimulation, we could also observe
peri-infarct depolarizations (PIDs) in the ischaemic
hemisphere during remote MCAO (Figure 1(b)). PIDs
occurred in 10/15 (67%) animals during remote MCAO
where it was assessed. Over all experiments using the
remote MCAO model, we had a success rate of 18 out
of 20 animals (90%) as assessed by a drop in CBF by at
least 30% of baseline (which equates to a drop to 45%
of true baseline when the CBF reduction by CCAO is
considered). The reasons for failure of remote MCAO
included resistance of the ﬁlament to advancing remo-
tely (one animal) and a loose guide cannula (one
animal) (see Supplementary Fig 1).
The remote MCAO model was chosen to carry out
evoked blood ﬂow and oxygen experiments immedi-
ately prior to occlusion, throughout the ischaemic
period, and immediately following reperfusion without
having to move the animal. Using the transcallosal
stimulation model (Supplementary Fig 2C) prior to
MCAO, we observed strong evoked CBF responses
(73% 40% (n¼ 6) of basal CBF) lasting the duration
of the stimulation in both somatosensory cortices
(Figure 2(a) shows only right cortex (ipsilateral to
MCAO) CBF, Suppl Movie 3). However, upon induc-
tion of remote MCAO where resting CBF drops in the
ipsilateral cortex, the maxima of evoked CBF responses
were signiﬁcantly reduced to 13% 10% (Tukey’s:
p¼ 0.0413, n¼ 6) of basal CBF (Figure 2(a) and (b)).
When reperfusion was restored by ﬁlament retraction,
evoked CBF responses partially recovered to
37% 29% (n¼ 6) of basal CBF (Figure 3(a) and
(b)) but were still signiﬁcantly decreased compared
with baseline when measured as maxima (Tukey’s:
p¼ 0.0067, Figure 2(b)) and area (Tukey’s: p¼ 0.0359,
Supplementary Fig 4C). Similar changes in evoked
tpO2 were also observed, whereby a strong transient
increase in tpO2 upon stimulation (99% (45–228%),
n¼ 3) was diminished following remote MCAO (1.1%
(0.2–2.1%), n¼ 3), and was partially restored upon
reperfusion (14% (10–51%), n¼ 3; Figure 2(c) and
(d)). Similar results were observed when area of tpO2
was measured following stimulation (Supplementary
Fig 4D). These results suggest that MCAO can lead
to abrupt attenuation of the evoked CBF and oxygen
response, which could be partially recovered upon
reperfusion.
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Cohort 2: Diminished evoked responses after remote
MCAO in the presence of alteplase
One advantage of the remote MCAOmodel is the ability
to investigate neurovascular coupling hyperacutely in the
presence or absence of vasoactive drugs. Endogenous
tPA has been shown to modulate neurovascular cou-
pling,14 and so we assessed the eﬀects of alteplase on
resting CBF and neurovascular coupling immediately
upon reperfusion following remote MCAO. Alteplase,
saline or L-arginine vehicle was infused immediately
upon ﬁlament withdrawal. In this cohort of animals,
remote MCAO induction produced a sudden drop in
resting CBF that partially rebounded, but ischaemia
was maintained throughout the MCAO period
(Tukey’s: all MCAO timepoints compared with pre-
MCAO had p< 0.0001, n¼ 9; Figure 3(a)). When the
pre-existing CCAO-induced CBF drop was taken into
account, CBF remained attenuated throughout the
ischaemic period (Tukey’s: all MCAO timepoints
(n¼ 9) compared with CCAO (n¼ 44) had p< 0.0001;
Figure 3(b)). Resting CMRO2 at the point of occlusion
was decreased (Tukey’s: p< 0.0001, n¼ 9), but was soon
restored to pre-MCAO levels and maintained at this
level throughout the ischaemic period (Figure 3(c)).
During remote MCAO, all animals (n¼ 9) had at least
one PID (mean¼ 3 PIDs, range 1–6) with the average
time to ﬁrst PID being 3.9min (range 2–7min).
Remote MCAO was followed by successful
reperfusion after retraction of the ﬁlament (Tukey’s:
p< 0.0001, n¼ 9; Figure 3(d) and (e)), while
alteplase did not inﬂuence CBF throughout the reper-
fusion period (Figure 3(d)). When normalising
to pre-CCAO values, resting CBF remained lower
Figure 2. Remote MCAO diminishes evoked CBF and tissue oxygen, which was partially reversed by reperfusion. (a) Meanþ SD
trace of the evoked CBF response to transcallosal stimulation pre-, during and post-remote MCAO. (b) Quantification (mean SD) of
the maximum change in CBF in response to transcallosal stimulation pre-, during and post-remote MCAO. N¼ 6 per group.
(c) Meanþ SD trace of the evoked tpO2 response to transcallosal stimulation pre-, during and post-remote MCAO. (d) Quantification
(median range) of the maximum change in tpO2 in response to transcallosal stimulation pre-, during and post-remote MCAO. N¼ 3
per group.
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(Tukey’s: p< 0.0001, n¼ 9) than baseline throughout
the reperfusion period, which was not aﬀected by
treatment group (Figure 3(e)). An increase in resting
CMRO2 was also observed upon reperfusion
(Tukey’s: p¼ 0.0037; n¼ 9) but recovered quickly to
baseline, and this was not aﬀected by treatment
group (Figure 3(f)). Only one animal out of all
cohort two animals (11%) during the 60min reperfu-
sion period presented a PID, which occurred at
45min following reperfusion onset.
Figure 3. Remote MCAO changes in resting CBF and oxygen metabolism were not affected by alteplase. (a) Resting CBF dropped
with remote MCAO, and then partially rebounded, but CBF remained attenuated compared with PRE-MCAO throughout the
ischaemic period. Note that PRE was recorded after CCA occlusion. (b) Conventional MCAO data show common carotid artery
occlusion (CCAO) drops CBF to 65% of baseline (n¼ 44)5 and so CBF values from (a) were transformed to obtain % CBF change with
respect to pre-CCAO. (c) Resting CMRO2 dropped at the point of remote MCAO but was restored to pre-MCAO levels throughout
the ischaemic period. (d) Resting CBF increased upon filament retraction following remote MCAO with no significant changes
between any treatment groups during the reperfusion period. These values were normalised to pre-MCAO after CCAO. (e) Same as
(d) except values were normalised to pre-MCAO before CCAO. Apart from the initial reperfusion, the resting CBF remained
significantly dampened throughout the reperfusion period and this was not affected by alteplase. (f) Resting CMRO2 increased upon
filament retraction following remote MCAO, but then decreased back to baseline levels throughout the reperfusion period. Resting
CMRO2 was not affected by alteplase. (a–c) had N¼ 9 at each time point and is presented as mean SD. (d–f) had N¼ 3 per group at
each time point and is presented as median range.
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Using the same transcallosal stimulation model as
described above, evoked CBF during remote MCAO
was diminished at all time points during the 90min
ischaemic period (Tukey’s: p< 0.0001; Figure 4(a)
(15 s stim CBF maxima), Supplementary Fig 5B (15 s
stim CBF area), Supplementary Fig 5C (2 s stim CBF
area)). Similar attenuation of evoked CMRO2 was also
observed during MCAO (Tukey’s: p< 0.0042, n¼ 9;
Figure 4(b)). An electrode placed into the somatosen-
sory cortex to measure excitatory post-synaptic poten-
tial (EPSP) and inhibitory post-synaptic potential
(IPSP; Suppl Fig 5A) revealed that there was a small
reduction in summed EPSP response upon remote
MCAO (Tukey’s: p¼ 0.0367, n¼ 9; Figure 4(c)) that
was not maintained throughout the ischaemic period
while IPSP was abolished upon remote MCAO
(Tukey’s: p< 0.0001, n¼ 9; Figure 4(d)).
Reperfusion partially recovered evoked CBF
responses (Tukey’s: p¼ 0.0146, n¼ 9) but remained
dampened throughout reperfusion (Tukey’s: p< 0.0001,
n¼ 9; Figure 4(d)). Reperfusion did not alter evoked
CMRO2 (Figure 4(f)). At 50min of reperfusion,
evoked EPSP was augmented (Tukey’s: p¼ 0.0086,
n¼ 9; Figure 4(g)) while IPSP remained attenuated
after reperfusion (Tukey’s: p< 0.0001, n¼ 9;
Figure 4(h)). Treatment with alteplase, L-arginine carrier
or saline did not aﬀect any of these parameters through-
out the reperfusion period (Figure 4(e)–(h), Suppl
Figs 5D, E) suggesting that alteplase does not produce
any acute eﬀects on neurovascular coupling.
Further to this, correlation analyses revealed that
during ischaemia evoked neuronal activity was sig-
niﬁcantly diminished and this correlated with the
decrease in evoked CBF (Pearsons r2¼ 0.62,
p< 0.001; Figure 5(a)) and evoked CMRO2 (Pearsons
r2¼ 0.25, p¼ 0.008; Figure 5(b)). This evoked CBF
decrease also correlated with a signiﬁcant decrease
in evoked CMRO2 (Pearsons r
2¼ 0.22, p¼ 0.008;
Figure 5(c)). This suggests that reduced resting CBF
by remote MCAO leads to diminished evoked neuronal
activity, which subsequently attenuates the evoked
blood ﬂow and metabolic responses. There was no sig-
niﬁcant correlation between the extent of evoked CBF
response and resting CBF during ischaemia (Pearsons
r2¼ 0.11, p¼ 0.053; Suppl Fig 6A).
During reperfusion, whilst there was a recovery of
evoked neuronal activity, this was not correlated with
an increase in evoked CBF (Pearsons r2¼ 0.05,
p¼ 0.274; Figure 5(d)) and CMRO2 (Pearsons
r2¼ 0.02, p¼ 0.532; Figure 5(e)) suggestive of a partial
uncoupling of neuronal, hemodynamic and metabolic
responses (breakdown of neurovascular coupling).
However, evoked metabolism correlated with evoked
CBF during reperfusion (Pearsons r2¼ 0.33, p¼ 0.002;
Figure 5(f)) indicating that uncoupling occurred
between the neuronal and hemodynamic responses.
Interestingly, evoked CBF during reperfusion was
also inversely correlated with levels of resting CBF
during ischaemia (Pearsons r2¼ 0.57, p¼ 0.019;
Suppl Fig 6B) and reperfusion (Pearsons r2¼ 0.25,
p¼ 0.008; Suppl Fig 6C), whereby the lower the resting
level of CBF, the higher the evoked CBF during
reperfusion.
Cohort 3: No diminished evoked responses 24 h fol-
lowing conventional MCAO
The remote MCAO model reduced evoked blood ﬂow
and metabolic responses during ischaemia and
impaired neurovascular coupling within the ﬁrst hour
of reperfusion. Since neurovascular coupling changes
might have been sustained beyond this, we used the
whisker stimulation model to assess neurovascular cou-
pling in animals exposed to the conventional 90min
MCAO model5 followed by recovery for 22.5 h. Sham
controls were used to compare the neurovascular cou-
pling eﬀects of MCAO. Median neurological deﬁcit was
greater 24 h after MCAO onset compared with sham
animals (Sham¼ 0 (range 0–1), MCAO¼ 5 (range
5–8), n¼ 3, Figure 6(a)). The whisker stimulation
model (10Hz) produced a strong evoked CBF response
that lasted for the duration of the stimulation
(Figure 6(b)). In contrast with the hyperacute reperfu-
sion time points where evoked CBF was only partially
restored, neurovascular coupling appears to recover by
24h as there were no diﬀerences in either evoked
CBF responses or local ﬁeld potentials between sham
and MCAO animals in the ischaemic hemisphere
(Figure 6(b)–(d)). The transcallosal stimulation model
at these frequencies activates pyramidal neurons within
the somatosensory cortex,21 which notably was not in
the infarcted area at 24h post-MCAO but in the peri-
infarct area that surrounds the core infarct (Figure 6(e)).
Discussion
In this study, we used a remote intraluminal ﬁlament
MCAO model of stroke to assess neurovascular cou-
pling prior to, during and after ischaemia. This model is
a crucial tool for studying hyperacute changes in CBF
and has the ability to assess the eﬀects of adjunct ther-
apy on neurovascular function in the early stages after
a stroke. The remote MCAO model leads to changes in
CBF and brain oxygenation consistent with the conven-
tional intraluminal ﬁlament MCAO model.22 We
showed here that evoked CBF responses were dimin-
ished during ischaemia compared with pre-MCAO,
alongside attenuated evoked tpO2, CMRO2 and neur-
onal activity. Upon reperfusion, while evoked excita-
tory neuronal activity recovered, there was only
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Figure 4. Remote MCAO changes in evoked CBF, oxygen metabolism and neuronal activity were not affected by alteplase. (a)
Remote MCAO decreased evoked CBF in response to transcallosal stimulation. (b) Remote MCAO diminished evoked CMRO2. (c)
Evoked EPSP was reduced initially following remote MCAO. (d) Remote MCAO diminished evoked IPSP. (e) Evoked CBF in response
to transcallosal stimulation during reperfusion was slightly increased compared with MCAO, attenuated compared with PRE-MCAO
but was not affected by alteplase. (f) Reperfusion and alteplase treatment did not affect evoked CMRO2. (g) Evoked EPSP increased at
50min of reperfusion but was not affected by alteplase. (h) Evoked IPSP remained abolished upon reperfusion in all treatment groups.
(a–d) had N¼ 9 at each time point and presented as mean SD. (e–h) had N¼ 3 per group at each time point and presented as
median range. All values were normalised to evoked changes pre-MCAO.
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partial restoration of evoked CBF and CMRO2 indica-
tive of disrupted neurovascular coupling. Furthermore,
since these hyperacute time points are recognised as the
critical periods for intervention in the clinical setting,
the remote MCAO model also allowed investigation
into the eﬀects of vasoactive drugs on neurovascular
coupling. In this study, we showed that the thrombo-
lytic alteplase did not aﬀect the neurovascular coupling
response upon reperfusion when administered at a clini-
cally relevant dose and route. The hyperacute
impairment in neurovascular coupling during the
ﬁrst 60min of reperfusion was not sustained at
22.5 h following 90min conventional MCAO, and so
neurovascular recovery of the peri-infarct tissue took
place during this time. Overall, the ability to assess
neurovascular coupling immediately upon ischaemia
and reperfusion using the remote MCAO model will
provide unique insight into the pathophysiology of
ischaemic brain injury and changes in CBF and
metabolism.
Figure 5. Correlations between evoked CBF, neuronal activity and metabolism during ischaemia and reperfusion. (a) There was a
significant correlation between evoked CBF and neuronal activity during ischaemia. (b) There was a significant correlation between
evoked CMRO2 and neuronal activity during ischaemia. (c) A significant correlation between evoked CBF and oxygen metabolism was
observed during remote MCAO. (d) There was no significant correlation between evoked CBF and neuronal activity during reper-
fusion. (e) There was no correlation between evoked CMRO2 and neuronal activity during reperfusion after remote MCAO. (f) There
was a significant correlation between evoked CBF and oxygen metabolism during reperfusion.
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Neurovascular deﬁcits following stroke have previ-
ously been reported in both animal9–12 and human stu-
dies,23 and these deﬁcits may be associated with
damaged neuronal connectivity and plasticity and
lead to problems related to brain repair. Most studies
have investigated later time points and showed that
whilst there were somatosensory deﬁcits in the days
following stroke that can recover during the following
weeks,24 at 10 weeks post-stroke there were functional
connectivity impairments that can contribute to long-
term deﬁcits in somatosensory function.12 Our investi-
gation into the hyperacute neurovascular eﬀects
revealed signiﬁcant changes in the evoked responses
upon transcallosal stimulation throughout ischaemia.
In particular, both evoked excitatory and inhibitory
neuronal activity was attenuated, which led to a
Figure 6. Neurovascular coupling is not impaired 24 h following 90min MCAO. (a) Median neuroscore 24 h following 90min MCAO
or sham. MCAO animals had greater neurological deficit than sham animals. (b) Mean SD trace of evoked CBF in response to 10Hz
whisker stimulation 24 h following sham or 90min MCAO. N¼ 3 per group. (c) Maximal CBF (median range) in response to 3 or
10Hz whisker stimulation was unaltered at 24 h between sham and MCAO groups. (d) Neuronal activity following 3Hz whisker
stimulation measured by the summed local field potential response (median range) was not different between sham and MCAO
groups at 24 h. (e) Representative TTC image of a brain section 24 h following 90min MCAO showing the location of infarction (white
with black outline) with an overlay (yellow) of the somatosensory cortex that had an increase in CBF evoked by whisker stimulation.
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decrease in evoked CBF, tpO2 and CMRO2 responses.
However, upon reperfusion, evoked inhibitory neur-
onal activity was diminished whilst evoked excitatory
neuronal activity was enhanced above baseline lead-
ing to its overactivation. This was associated with
attenuated evoked CBF and CMRO2 responses, and
correlation analyses suggest that there was impair-
ment in the link between recovery of evoked neuronal
activity and evoked hemodynamic and metabolic
responses during reperfusion. Further experiments
using the conventional MCAO model showed that
this impaired neurovascular coupling response was
not present by 24 h following MCAO onset.
Stimulation at the frequencies used activates neurons
only within the somatosensory cortex,21 which is
located in the peri-infarct region outside the ischaemic
core at 24 h following 90min MCAO. These ﬁndings
suggest that during ischaemia, neurovascular cou-
pling remains intact but overall activity is downregu-
lated; in the hyperacute phase (ﬁrst hour of
reperfusion) neurovascular coupling is impaired,
which is followed by recovery in the acute phase
(ﬁrst 24 h of reperfusion).
In both cohorts 1 and 2, there was only a small
recovery of evoked CBF responses upon transcallosal
stimulation during reperfusion, even in the presence of
excessive excitatory neuronal activity. This suggests
that there is some impairment in neurovascular cou-
pling during this time. It is currently unknown how
long this impairment will persist for, but its sustained
nature is surprising given the restoration of oxygen and
glucose that accompanies reperfusion. One reason
could be that during ischaemia brain cells conserve
energy due to limited supply, but upon restoration of
blood ﬂow, the cellular machinery to produce energy
and subsequent signalling from neurons and glia to the
vasculature may remain impaired.8 Another contribu-
tor may be that in this model, the CCA remains ligated
after ﬁlament retraction, meaning that full reperfusion
does not occur, which could account for attenuated
neurovascular coupling. Additional studies are needed
to test these hypotheses.
In 67% of animals assessed, PIDs occurred during
remote MCAO with only one animal from all cohorts
(7%) exhibiting a PID during 60min of reperfusion.
Spreading depolarizations have long been reported to
impair vascular reactivity in the cortex.25–27 A recent
study has suggested that during ischaemia, somatosen-
sory stimulation itself can lead to a transient worsening
of the supply–demand mismatch within the brain, trig-
gering a PID.28 The total period of depolarization con-
tributes to ischaemic injury,29 and so it is conceivable
that the neurovascular impairment seen in the present
study is partially related to the occurrence of PIDs, in
addition to ischaemia-reperfusion injury.
Alteplase, a thrombolytic, is administered to ischae-
mic stroke patients to restore blood ﬂow, but only a
minority of patients beneﬁt from this therapeutic strat-
egy.13 Given that endogenous tPA plays a role in neu-
rovascular coupling through the nitric oxide pathway,14
we hypothesised that exogenous rtPA, given as alte-
plase, may alter neurovascular coupling during the
ﬁrst hour of reperfusion following MCAO. Since alte-
plase contains high levels of L-arginine, the substrate of
nitric oxide production, and L-arginine has been specu-
lated to fuel some of the non-thrombolytic eﬀects of
alteplase,30 we also assessed the eﬀect of the vehicle
containing L-arginine on resting CBF and neurovascu-
lar coupling following MCAO. In our hands, neither
alteplase nor its L-arginine carrier altered resting CBF
and CMRO2, evoked neuronal activity, CBF and
CMRO2 upon stimulation during the ﬁrst hour of
reperfusion. This suggests that alteplase has no eﬀect
on the neurovascular coupling response during reperfu-
sion, and that any eﬀect on resting CBF remain solely
limited to its thrombolytic activity. This is in line with a
recent study that showed that alteplase had no eﬀect on
CBF immediately after conventional intraluminal ﬁla-
ment MCAO nor neurotoxicity 24 h later.5
One advantage of the remote MCAO model is the
ability to examine neurovascular coupling using a range
of neuroimaging techniques prior to occlusion and
immediately after ischaemia and reperfusion have
occurred. This approach allows each animal to act as
its own control and is important given most neurovas-
cular coupling studies using animal models of stroke
are unable to obtain baseline measurements prior to
ischaemia, necessitating the use of sham animals to
compare evoked changes. This can be observed with
cohort 3 where sham controls were used rather than a
pre-MCAO control, which could account for diﬀer-
ences in evoked responses between the remote MCAO
and conventional MCAO models.
We appreciate that there are a number of limitations
to this study. The invasive carotid surgery, tracheotomy
and ventilation for control of physiological parameters,
and craniotomies meant that recovery experiments were
not an option. Hence, the period of investigation was
limited to 1 h of reperfusion following 90min MCAO.
Continuous CBF measurements could only be taken
following CCAO, so normalising to CBF post-CCAO
does not reﬂect true CBF. The extent of CBF drop
upon CCAO can inﬂuence outcome following
MCAO,31 and so it is important that CBF monitoring
occurs upon CCAO in future studies. Upon ﬁlament
insertion remotely, there was a sharp decrease in CBF
indicating ischaemia had occurred but this was fol-
lowed rapidly by a partial rebound of CBF (this was
particularly evident in cohort 2 with LSCI). This
rebound has been observed previously32 and could be
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due to recruitment of collateral vessels to the ischaemic
area as an attempt to restore CBF.
The remote MCAO model on the stereotaxic frame
has also been developed independently in the mouse not
for neurovascular coupling assessment but to investi-
gate the eﬀects of ischaemia and reperfusion on oxy-
genation in the brain.33 Previous studies have
successfully attempted the remote MCAO model in
the magnet to investigate acute changes in MRI param-
eters following ischaemia.34 However, our personal
experience was that the remote MCAO model in the
magnet was very diﬃcult to reliably reproduce due to
the distance (approximately 100 cm) between the
indwelling monoﬁlament and access to the guide can-
nula to control ﬁlament position. If the remote MCAO
model could be reproducibly developed for MRI stu-
dies, this will be a powerful technique to assess the
dynamic changes in brain function and metabolism fol-
lowing stroke. Nevertheless, our study and the recently
published mouse study, advocate the remote MCAO
model as a powerful tool on the bench to examine the
hyperacute eﬀects of MCAO on blood ﬂow, oxygen-
ation, neuronal activity and metabolism in the brain.
In conclusion, the hyperacute eﬀects of ischaemia
and reperfusion on neurovascular coupling can be
investigated using a remote MCAO model. Signiﬁcant
changes to evoked responses were observed during
ischaemia, which only partially recovered during the
initial stages of reperfusion. In particular, the evoked
neuronal activity upon stimulation did not lead to pro-
nounced evoked CBF and metabolic responses
throughout the ﬁrst 60 min of reperfusion, and these
responses were not aﬀected by the administration of the
thrombolytic alteplase. However, the hyperacute
diminished responses were restored by 22.5 h of reper-
fusion using the conventional MCAO model. This
study provides insight into brain activity changes
initiated upon ischaemia and the time-dependent recov-
ery of neurovascular responses following reperfusion.
Further studies that are able to relate hyperacute
modulation of neurovascular coupling following
MCAO to longer term tissue, neurovascular imaging
or even behavioural outcomes will be useful for
developing new hyperacute ‘neurovascular’ (as opposed
to principally vascular or CBF-mediated) interventions
that could protect the brain after a stroke.
Funding
The author(s) disclosed receipt of the following ﬁnancial sup-
port for the research, authorship, and/or publication of this
article: The work presented in this manuscript was funded by
a Fondation Leducq Transatlantic Network of Excellence
(ML, AMB). CM was supported by a Royal Society
University Research Fellowship and a Wellcome Trust
Research Project Grant (WT093223). AAN was supported
by a Radcliﬀe Department of Medicine Scholarship. NRS
was funded by Cancer Research UK (C5255/A15935). AMB
and BAS were funded by the Medical Research Council (MR/
M022757/1).
Declaration of conflicting interests
The author(s) declared the following potential conﬂicts of
interest with respect to the research, authorship, and/or pub-
lication of this article: AMB is a senior medical science advi-
sor and co-founder of Brainomix, a company that develops
electronic ASPECTS (e-ASPECTS), an automated method to
evaluate ASPECTS in stroke patients. All other authors
declare no conﬂict of interest.
Authors’ contributions
The experiments were conceived and designed by BAS, CM,
BMW, NRS, MLa and AMB. Experiments were carried out
by BAS, JCF, CM, AAN, BMW and MLø. Experiments were
analysed by BAS, JCF, CM, AAN, BMW, HP and YC. The
paper was written by BAS and edited by all authors.
Supplementary material
Supplementary material for this paper can be found at http://
jcbfm.sagepub.com/content/by/supplemental-data
References
1. Sutherland BA, Minnerup J, Balami JS, et al.
Neuroprotection for ischaemic stroke: Translation from
the bench to the bedside. Int J Stroke 2012; 7: 407–418.
2. Neuhaus AA, Rabie T, Sutherland BA, et al. Importance
of preclinical research in the development of neuropro-
tective strategies for ischemic stroke. JAMA Neurol 2014;
71: 634–639.
3. Sutherland BA, Papadakis M, Chen RL, et al. Cerebral
blood flow alteration in neuroprotection following cere-
bral ischemia. J Physiol 2011; 589: 4105–4114.
4. Nagel S, Papadakis M, Chen R, et al. Neuroprotection by
dimethyloxalylglycine following permanent and transient
focal cerebral ischemia in rats. J Cereb Blood Flow Metab
2011; 31: 132–143.
5. Sutherland BA and Buchan AM. Alteplase treatment
does not increase brain injury after mechanical middle
cerebral artery occlusion in the rat. J Cereb Blood Flow
Metab 2013; 33: e1–e7.
6. Hall CN, Reynell C, Gesslein B, et al. Capillary pericytes
regulate cerebral blood flow in health and disease. Nature
2014; 508: 55–60.
7. Attwell D, Buchan AM, Charpak S, et al. Glial and neur-
onal control of brain blood flow. Nature 2010; 468:
232–243.
8. Jackman K and Iadecola C. Neurovascular regulation in
the ischemic brain. Antioxid Redox Signal 2015; 22:
149–160.
9. Shen Q, Ren H, Cheng H, et al. Functional, perfusion
and diffusion MRI of acute focal ischemic brain injury.
J Cereb Blood Flow Metab 2005; 25: 1265–1279.
10. Kim YR, Huang IJ, Lee SR, et al. Measurements of
BOLD/CBV ratio show altered fMRI hemodynamics
Sutherland et al. 2507
during stroke recovery in rats. J Cereb Blood Flow Metab
2005; 25: 820–829.
11. van Meer MP, van der Marel K, van der Sprenkel JW,
et al. MRI of bilateral sensorimotor network activation in
response to direct intracortical stimulation in rats after
unilateral stroke. J Cereb Blood Flow Metab 2011; 31:
1583–1587.
12. van Meer MP, van der Marel K, Wang K, et al. Recovery
of sensorimotor function after experimental stroke cor-
relates with restoration of resting-state interhemispheric
functional connectivity. J Neurosci 2010; 30: 3964–3972.
13. Balami JS, Hadley G, Sutherland BA, et al. The exact
science of stroke thrombolysis and the quiet art of patient
selection. Brain 2013; 136: 3528–3553.
14. Park L, Gallo EF, Anrather J, et al. Key role of tissue
plasminogen activator in neurovascular coupling. Proc
Natl Acad Sci USA 2008; 105: 1073–1078.
15. Hoffmeyer HW, Enager P, Thomsen KJ, et al. Nonlinear
neurovascular coupling in rat sensory cortex by activa-
tion of transcallosal fibers. J Cereb Blood Flow Metab
2007; 27: 575–587.
16. Fordsmann JC, Ko RW, Choi HB, et al. Increased
20-HETE synthesis explains reduced cerebral blood
flow but not impaired neurovascular coupling after cor-
tical spreading depression in rat cerebral cortex.
J Neurosci 2013; 33: 2562–2570.
17. Piilgaard H and Lauritzen M. Persistent increase in
oxygen consumption and impaired neurovascular cou-
pling after spreading depression in rat neocortex.
J Cereb Blood Flow Metab 2009; 29: 1517–1527.
18. Bardutzky J, Shen Q, Henninger N, et al. Differences in
ischemic lesion evolution in different rat strains using dif-
fusion and perfusion imaging. Stroke 2005; 36:
2000–2005.
19. Sutherland BA, Rabie T and Buchan AM. Laser Doppler
flowmetry to measure changes in cerebral blood flow.
Methods Mol Biol 2014; 1135: 237–248.
20. Garcia JH, Wagner S, Liu KF, et al. Neurological deficit
and extent of neuronal necrosis attributable to middle
cerebral artery occlusion in rats. Statistical validation.
Stroke 1995; 26: 627–634. (discussion 635.
21. Enager P, Piilgaard H, Offenhauser N, et al. Pathway-
specific variations in neurovascular and neurometabolic
coupling in rat primary somatosensory cortex. J Cereb
Blood Flow Metab 2009; 29: 976–986.
22. Hou H, Li H, Dong R, et al. Real-time monitoring of
ischemic and contralateral brain pO2 during stroke by
variable length multisite resonators. Magn Reson
Imaging 2014; 32: 563–569.
23. Salinet AS, Robinson TG and Panerai RB. Cerebral
blood flow response to neural activation after acute ische-
mic stroke: a failure of myogenic regulation? J Neurol
2013; 260: 2588–2595.
24. van der Zijden JP, Bouts MJ, Wu O, et al. Manganese-
enhanced MRI of brain plasticity in relation to functional
recovery after experimental stroke. J Cereb Blood Flow
Metab 2008; 28: 832–840.
25. Lauritzen M. Long-lasting reduction of cortical blood
flow of the brain after spreading depression with pre-
served autoregulation and impaired CO2 response.
J Cereb Blood Flow Metab 1984; 4: 546–554.
26. Lauritzen M and Diemer NH. Uncoupling of cerebral
blood flow and metabolism after single episode of cortical
spreading depression in the rat brain. Brain Res 1986;
370: 405–408.
27. Wahl M, Lauritzen M and Schilling L. Change of cere-
brovascular reactivity after cortical spreading depression
in cats and rats. Brain Res 1987; 411: 72–80.
28. von Bornstadt D, Houben T, Seidel JL, et al. Supply-
demand mismatch transients in susceptible peri-infarct
hot zones explain the origins of spreading injury depolar-
izations. Neuron 2015; 85: 1117–1131.
29. Dijkhuizen RM, Beekwilder JP, van der Worp HB, et al.
Correlation between tissue depolarizations and damage
in focal ischemic rat brain. Brain Res 1999; 840: 194–205.
30. Harston GW, Sutherland BA, Kennedy J, et al. The con-
tribution of L-arginine to the neurotoxicity of recombin-
ant tissue plasminogen activator following cerebral
ischemia: a review of rtPA neurotoxicity. J Cereb Blood
Flow Metab 2010; 30: 1804–1816.
31. Riva M, Pappada GB, Papadakis M, et al. Hemodynamic
monitoring of intracranial collateral flow predicts tissue
and functional outcome in experimental ischemic stroke.
Exp Neurol 2012; 233: 815–820.
32. Muller TB, Haraldseth O and Unsgard G.
Characterization of the microcirculation during ischemia
and reperfusion in the penumbra of a rat model of tem-
porary middle cerebral artery occlusion: a laser Doppler
flowmetry study. Int J Microcirc Clin Exp 1994; 14:
289–295.
33. Burrows FE, Bray N, Denes A, et al. Delayed reperfusion
deficits after experimental stroke account for increased
pathophysiology. J Cereb Blood Flow Metab 2015; 35:
277–284.
34. Lythgoe MF, Thomas DL, Calamante F, et al. Acute
changes in MRI diffusion, perfusion, T(1), and T(2) in
a rat model of oligemia produced by partial occlusion of
the middle cerebral artery. Magn Reson Med 2000; 44:
706–712.
2508 Journal of Cerebral Blood Flow & Metabolism 37(7)
